ArticleEuropean heart journal. Digital health2026
The ethical application of artificial intelligence in digital health: patients' knowledge, pulmonary hypertension, and the problem of misrecognition.
Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- How should patient knowledge trigger clinical action in artificial intelligence-enabled pulmonary hypertension care?European heart journal. Digital health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is increasingly being introduced into healthcare to improve efficiency, accuracy, and personalisation. Debate has centred on concerns such as bias, safety, and transparency. We argue that another problem deserves much more attention: misrecognition. By this we mean the risk that digital systems know patients mainly through what is easiest to measure and record, while overlooking what is hardest to code but most central to living with illness. Drawing on the concept of epistemic injustice, we suggest that patients may be disbelieved, misunderstood or required to translate complex, embodied, and relational experiences into clinical categories that fit poorly. Our point is not that patients' accounts fall outside data, but that all data require interpretation, and patient and caregiver inputs are often treated as lower-status knowledge in decisions about burden, benefit, and value. These risks do not arise uniformly across computational tools: they take different forms in task-specific machine learning systems used for classification or prediction, and in generative AI systems, including large language models, used to process or generate text. AI may deepen the problem by relying on proxies such as cost, utilization, and adherence thereby hardening narrow understandings of illness into technical systems. Using pulmonary hypertension (PH) as a case, we reflect on patient-led outcome measures such as emPHasis-10 to show that measurement is never neutral: it shapes what counts as legitimate knowledge, meaningful change, and good care. The key question is not only whether AI is accurate or fair, but what patient experiences become visible within it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.